Home›Stock Screener›Divis Laboratories›Quarterly Results

Divis Laboratories Quarterly Results

Latest Quarter Net Profit
₹751 Cr
QMar 2026
Quarterly Results

Divis Laboratories quarterly results. In Mar 2026, Divis Laboratories (DIVISLAB) reported revenue ₹2,986 Cr and net profit ₹751 Cr — revenue +11.8% YoY. Review Divis Laboratories price earnings to evaluate earnings-based valuation against sector peers.

DIVISLAB Quarterly Results — Revenue, Profit & EPS Highlights

Divis Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Divis Laboratories share price today.

  • Revenue of ₹2,986 Cr in Mar 2026 (-5.0% vs Jun 2026, +11.8% vs Mar 2025)
  • Net Profit of ₹751 Cr in Mar 2026 (-16.7% vs Jun 2026, +13.4% vs Mar 2025)
  • EBITDA of ₹1,089 Cr in Mar 2026 (-17.4% vs Jun 2026)
  • Operating Margin of 33.0% in Mar 2026 (-8.0pp vs Jun 2026)
  • Earnings Per Share of ₹28.31 in Mar 2026 (-16.6% vs Jun 2026)

Divis Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

DIVISLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 2,986 3,144 2,860 2,671 2,529 -5.0% 11.8%
Net Profit (₹ Cr) 751 902 689 662 545 - -
EBITDA (₹ Cr) 1,089 1,319 1,033 972 848 - -
EPS (₹) 28.31 33.95 25.97 24.93 20.49 - -
Operating Margin (%) 33.0% 41.0% 33.0% 34.0% 30.0% - -

DIVISLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Divis Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check DIVISLAB market value to track the company's total market size over time.

Profitability Ratios

Profit Margin 25.2%
EBITDA Margin 36.5%
Operating Margin 33.0%
ROE (Annual) 17.9%

Balance Sheet Highlights

Total Assets ₹20,033 Cr
Total Equity ₹16,761 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,229 Cr

Cash Flow Analysis

Operating Cash Flow ₹2,738 Cr
Investing Cash Flow ₹-2,219 Cr
Financing Cash Flow ₹-804 Cr
Net Cash Flow ₹-285 Cr

Current Market Data

Current Price ₹9162.00
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 2,671
Sept 2025 2,860
Jun 2026 3,144
Mar 2026 2,986

Net Profit Trend (₹ Cr)

Mar 2025 662
Sept 2025 689
Jun 2026 902
Mar 2026 751

Operating Margin Trend (%)

Mar 2025 34.0%
Sept 2025 33.0%
Jun 2026 41.0%
Mar 2026 33.0%

DIVISLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Divis Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Cipla
Mar 2026 		₹106,152.60 Cr 1330.9 6,612 543 -9.3% - 8.2% 193.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores